Literature DB >> 10540182

Externalization of tropomyosin isoform 5 in colon epithelial cells.

K V Kesari1, N Yoshizaki, X Geng, J J Lin, K M Das.   

Abstract

Ulcerative colitis (UC) is associated with autoantibody response to a cytoskeletal protein, human tropomyosin (hTM) isoform-5 (hTM5). Because hTM5 is an intracellular protein, it may remain inaccessible to the autoantibodies. Therefore, we have investigated the possibility of externalization of hTM5 in colon epithelial cells. Freshly isolated colonic and small intestinal epithelial cells and LS-180 colon cancer cell line were examined for surface expression of hTM5 by flow cytometric analysis using hTM isoform-specific MoAbs. The extracellular release of hTM5 was determined by Western blot and radioimmunoprecipitation analyses. Physical association of hTM5 with a membrane-associated colon epithelial protein (CEP) was examined by co-immunoprecipitation of hTM5 with anti-CEP MoAb, and CEP with anti-hTM5 MoAb. Cell surface expression of hTM5 was observed in colonic epithelial and LS-180 cells but not in small intestinal epithelial cells. LS-180 cells spontaneously released hTM5 as well as CEP into the culture medium that was significantly stimulated by a calcium ionophore, A23187, but inhibited by phorbol-12-myristate-13-acetate, monensin and methylamine. Co-immunoprecipitation experiments revealed that hTM5 forms a complex with CEP. We conclude that hTM5 is externalized in colon but not in small intestinal epithelial cells. The physical association of hTM5 with CEP suggests a possible chaperone function of CEP in the transport of hTM5, a putative target autoantigen in UC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540182      PMCID: PMC1905432          DOI: 10.1046/j.1365-2249.1999.01046.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Specificity of dimer formation in tropomyosins: influence of alternatively spliced exons on homodimer and heterodimer assembly.

Authors:  M Gimona; A Watakabe; D M Helfman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

2.  Autoimmunity and ulcerative colitis: can two enigmas make sense together?

Authors:  P Brandtzaeg
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

3.  Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis.

Authors:  L Biancone; A Mandal; H Yang; T Dasgupta; A O Paoluzi; A Marcheggiano; P Paoluzi; F Pallone; K M Das
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

4.  Expression of a unique protein on colon cancer cells that reacts with a novel monoclonal antibody and ulcerative colitis serum.

Authors:  T Hassan; Y Kanisawa; S Meyers; A Dasgupta; K M Das
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

5.  The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.

Authors:  J M Whitelock; A D Murdoch; R V Iozzo; P A Underwood
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

6.  A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody.

Authors:  S Bhagat; K M Das
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

7.  Regulated and unregulated pathways for MUC2 mucin secretion in human colonic LS180 adenocarcinoma cells are distinct.

Authors:  D J McCool; J F Forstner; G G Forstner
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

8.  Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease.

Authors:  A Mizoguchi; E Mizoguchi; C Chiba; G M Spiekermann; S Tonegawa; C Nagler-Anderson; A K Bhan
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

9.  Forced expression of chimeric human fibroblast tropomyosin mutants affects cytokinesis.

Authors:  K S Warren; J L Lin; J P McDermott; J J Lin
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

10.  Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity.

Authors:  L Liao; R Sindhwani; M Rojkind; S Factor; L Leinwand; B Diamond
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

2.  The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.

Authors:  Jing-Chuan Zhang; Fernando Donate; Xiaoping Qi; Nicholas P Ziats; Jose C Juarez; Andrew P Mazar; Yuan-Ping Pang; Keith R McCrae
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-26       Impact factor: 11.205

Review 3.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

4.  Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5.

Authors:  E K Onuma; P S Amenta; K Ramaswamy; J J Lin; K M Das
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

5.  Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia.

Authors:  Livia Biancone; Emma Calabrese; Giampiero Palmieri; Carmelina Petruzziello; Sara Onali; Giuseppe-Sigismondo Sica; Marta Cossignani; Giovanna Condino; Kiron-Moy Das; Francesco Pallone
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

6.  Accumulation of tropomyosin isoform 5 at the infection sites of host cells during Cryptosporidium invasion.

Authors:  Steven P O'Hara; Jim Jung-Ching Lin
Journal:  Parasitol Res       Date:  2006-02-15       Impact factor: 2.289

7.  mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).

Authors:  Koushik K Das; Hong Xiao; Xin Geng; Carlos Fernandez-Del-Castillo; Vicente Morales-Oyarvide; Ebubekir Daglilar; David G Forcione; Brenna C Bounds; William R Brugge; Martha B Pitman; Mari Mino-Kenudson; Kiron M Das
Journal:  Gut       Date:  2013-11-25       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.